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Background: We conducted this retrospective study to analyze the relationship between the distance of the
proximal resection margin (PRM) and the pattern of recurrence in patients with gastric cancer who underwent
curative gastrectomy.
Methods: In our series, there were 774 patients who underwent curative gastrectomy for gastric adenocarcinoma.
Thus, we classified our clinical series of patients into the distal gastrectomy group (n = 529) and the total
gastrectomy group (n = 245). The clinical pathologic data and PRM distance were collected. Univariate and
multivariate analyses were performed to evaluate association between PRM distance and locoregional recurrence.
Results: The mean distance of the PRM was 4.03 cm in the total gastrectomy group. The distance of the PRM had
a significant correlation with advanced T-stage, advanced N-stage,vascular invasion,lymphatic invasion, neural
invasion, histological undifferentiation, greater tumor size, and the upper third of the tumor location. On multivariate
analysis, tumor recurrence showed only the independent prognostic factor N-stage (P <0.023). The mean distance of
the PRM was 6.4 cm in the distal gastrectomy group. The distance of the PRM had a significant correlation with the
advanced T-stage, advanced N-stage, younger age, vascular invasion, histological undifferentiation, greater tumor size,
and the middle third of tumor location. On multivariate analysis, tumor recurrence showed three independent
prognostic factors, N-stage (P <0.001), vascular invasion (P = 0.009), and lower third tumor location (P = 0.035). The total
gastrectomy of locoregional recurrence was related to N-stage (P = 0.039), and the distal gastrectomy of locoregional
recurrence was related to T-stage (P = 0.021). Study on the disease-free survival, PRM distance, and locoregional
recurrence was not statistically relevant in both the total and distal gastrectomy group (P = 0.565 and P = 0.584,
respectively).
Conclusions: Our results indicate that a sufficient resection margin is not the absolute factor associated with the rate
of survival and recurrence, although it is a key prognostic factor. The locoregional recurrence had no significant
correlation with the distance of the PRM after curative gastrectomy.
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Gastric cancer is the fourth most prevalent malignancy
in Western countries, and its incidence is the highest in
Korea [1,2]. It is widely accepted that surgery is the first
line of therapy in patients with gastric cancer, for whom
curative marginal resection is the only method for in-
creasing the survival rate. Curative gastric cancer surgery
basically includes stomach resection, lymph node dissec-
tion, and reconstruction. In patients with gastric cancer,
surgical interventions are routinely performed consider-
ing both their conditions and cancer characteristics. To
date, active studies have been conducted to identify
prognostic factors in these patients. Thus, the pathologic
condition after radical surgical resection has been estab-
lished as the key prognostic factor. Both the lack of inva-
sion of cancer cells at the resection margin and the
appropriate dissection of surrounding lymph nodes are
essential for obtaining successful treatment outcomes of
curative resection [3].
It is mostly recommended that the resection margin
be remote from the margin of the tumor for the preven-
tion of its recurrence. In association with this, several
studies have reported that the inadequate resection mar-
gin is related to locoregional recurrence [4-6]. Currently,
however, there are no established guidelines for the dis-
tance of the resection margin; it is routinely subject to
surgeons’ technical expertise. The first part of the duo-
denum, 1 to 2 cm distal to the pylorus, is routinely
used as the distal resection margin (DRM) in gastrec-
tomy. However, the distance of the proximal resection
margin (PRM) remains controversial, despite the fact
that it is a key factor that is associated with the extent
of gastrectomy.
We conducted this retrospective study to analyze the
relationship between the distance of the PRM and the




We performed surgical operations for a total of 896 pa-
tients with gastric adenocarcinoma at department of
Memorial Jin Pok Kim, Korea Gastric Cancer Center,
Inje Medical College, Seoul Paik Hospital, Seoul, Korea
between September 2002 and December 2006. Of these,
122 patients were excluded because of other synchron-
ous or metachronous cancers, positive surgical margins,
or palliative treatment for gastric cancer. Therefore, 774
patients who were treated with curative gastrectomy
were enrolled in the current study. Of these, 529 who
underwent distal gastrectomy (29 underwent Billroth I
surgery and 500 underwent Billroth II surgery) and 245
who underwent total gastrectomy. Thus, our clinical series
of patients were classified into the distal gastrectomygroup (n = 529) and the total gastrectomy group (n = 245).
Types of surgical procedure were determined by the at-
tending surgeon’s preference, mainly based on the gastric
cancer treatment guidelines of Japan [3].
Patients’ clinical pathological data was collected from
medical and computerized records. Based on pathologic
examination, we retrospectively analyzed the clinical stage,
T- and N-stage, tumor size, histologic type, Lauren’s classi-
fication, venous, lymphatic, and neural invasion, tumor lo-
cation, and the distance of the PRM. The distance of the
PRM was defined as the distance extending from the
proximal limit of the lesion to the site of the resection. It
was not consistent with the intraoperative measurement.
It was measured based on the results obtained from surgi-
cal specimens placed in 10% formalin solution for more
than 12 hours. It was routinely evaluated using an intraop-
erative frozen section biopsy in all the patients. We ana-
lyzed the relationship between various clinicopathological
factors and the recurrence, including the locoregional re-
currence in particular.
The study population included patients who underwent
radical gastrectomy with D2 lymphadenectomy. We made
a diagnosis of cancer recurrence on physical examination,
radiologic assessment, and endoscopy. Recurrences were
classified as locoregional recurrence, hematogenous me-
tastasis, peritoneal carcinomatosis, and multiple metasta-
ses. Main patterns of recurrence were recorded as the first
site of detection at the time of diagnosis. By definition, the
locoregional recurrences include local lymph node metas-
tasis, extraluminal recurrence, recurrence within the gas-
tric remnant stomach, and anastomotic recurrence after
gastrectomy. The tumor stage was reported according to
the sixth edition of the tumor-node-metastasis (TNM)
classification of malignant tumor established by the Inter-
national Union Against Cancer (UICC) [7]. Our clinical
series of patients were followed up on until December
2011, with a mean follow-up period of 45 months (range:
1 to 111 months).
We obtained approval for this study from the Institu-
tional Review Board at Inje university Paik Hospital.
Written informed consent was obtained from patient for
the publication of this report and any accompanying
images.
Statistical analysis
Statistical analysis was done using SPSS version 12.0 for
Windows (SPSS, Inc., Chicago, Illinois, United States).
All data was expressed as mean ± standard definition
(SD). A P-value of <0.05 was considered to be statisti-
cally significant. Independent sample Student’s t-tests
were used to analyze the age, tumor size, and the dis-
tance of the PRM. In addition, the chi-squared test was
used to analyze the differences in the above variables
between the two groups. Furthermore, a log-rank test
Table 1 Clinicopathological factors depending on the
distance of the proximal resection margin (PRM) in the
patients who underwent curative total gastrectomy
Parameter PRM (cm) P value
≤2 2 - 4 ≥4
Gender 0.305
Male 35 42 62 139
Female 33 31 42 106
Age (years) 0.403
≤60 28 35 50 113
>60 40 38 54 132
T-stage <0.001
T1 2 21 36 59
T2 24 17 37 78
T3 40 28 29 97
T4 2 7 2 11
N-stage <0.001
N0 11 27 52 90
N1 14 19 23 56
N2 13 8 10 31
N3 30 19 19 68
Vascular invasion 0.007
Absent 37 54 78 169
Present 31 19 26 76
Lymphatic invasion 0.003
Absent 7 23 33 63
Present 31 19 71 182
Neural invasion <0.001
Absent 6 28 37 71
Present 62 45 67 174
Histology 0.045
Differentiated 13 18 34 65
Undifferentiated 55 55 70 180
Lauren’s classification 0.316
Intestinal 9 16 28 53
Diffuse 43 42 49 134
Mixed 16 15 27 58
Tumor size (cm) <0.001
≤2 0 6 13 19
2 - 5 8 26 43 77
>5 60 41 48 149
Tumor location <0.001
Lower third 0 1 13 14
Middle third 13 34 73 120
Upper third 34 31 18 83
Entire 21 7 0 28
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used to analyze the disease-free survival (DFS) and the
distance of the PRM. The Cox proportional hazards
model and logistic regression tests were employed for
multivariate analysis.
Results
Baseline and demographic data of the patients
In our series, there were 529 patients who underwent
distal gastrectomy and 245 who underwent total gastrec-
tomy. Thus, we classified our clinical series of patients
into the distal gastrectomy group (n = 529) and the total
gastrectomy group (n = 245). The mean age of the pa-
tients was 60 years (range: 24 to 88 years) in the distal
gastrectomy group and 60 years (range: 24 to 87 years)
in the total gastrectomy. The male-to-female ratio was
1.3:1.0 in the total gastrectomy group and 3.5:1.0 in the
distal gastrectomy group. In both groups, sex and age
had no significant correlation with the distance of the
PRM, with the exception of age in the distal gastrectomy
group. It is likely, early cancer is probably more, statis-
tical significance was observed, that there is no clinical
significance.
In both groups, the sex had no significant correlation
with the distance of the PRM. But, age in the distal gas-
trectomy group was correlated with PRM diastnace. It is
likely, early cancer is many subtota gastrectomy group, it
was observed a statistically significant, but it seems not
to be clinically significant.
The distance of the proximal resection margin in the total
gastrectomy group
The mean distance of the PRM was 4.03 cm in the total
gastrectomy group. That is, there were 68 (27.8%), 73
(29.8%), and 104 (42.4%) patients where the distance of
the PRM was <2 cm, 2 to 4 cm, and >4 cm, respectively.
The distance of the PRM had a significant correlation
with advanced T-stage (P <0.001), advanced N-stage
(P <0.001), vascular invasion (P = 0.007), lymphatic inva-
sion (P = 0.003), neural invasion (P <0.001), histological
undifferentiation (P = 0.045), greater tumor size (P <0.001),
and the upper third of the tumor location (P <0.001)
(Table 1).
There were 81 patients who had a tumor recurrence;
there were 16 cases of locoregional recurrence, 41 cases
of peritoneal carcinomatosis, 11 cases of hematogenous
metastasis, and 13 cases of multiple metastases. In
addition, the recurrence was found to have a significant
correlation with T-stage (P <0.001), N-stage (P <0.001),
PRM (P = 0.032), vascular invasion (P <0.001), lymphatic
invasion (P <0.001), neural invasion (P <0.001), histology
(P = 0.004), Lauren’s classification (P = 0.006), tumor size
(P <0.001), and tumor location (P <0.001) (Table 2).
Multivariate analysis performed by applying logistic
Table 2 Correlations with clinicopathological factors, recurrence, and locoregional recurrence in the patients who
underwent curative total gastrectomy
Parameter Recurrence P value Locoregional recurrence P value
Negative Positive Negative Positive
Gender 0.592 <0.001
Male 95 44 29 15
Female 69 37 36 1
Age (years) 0.655 0.869
≤60 74 39 31 8
>60 90 42 34 8
T-stage <0.001 0.917
T1 59 0 0 0
T2 62 16 13 3
T3 39 58 46 12
T4 4 7 6 1
N-stage <0.001 0.013
N0 83 7 7 0
N1 42 14 7 7
N2 13 18 15 3
N3 26 42 36 6
Vascular invasion <0.001 0.400
Absent 131 38 32 6
Present 33 43 33 10
Lymphatic invasion <0.001 0.309
Absent 59 4 4 0
Present 105 77 61 16
Neural invasion <0.001 0.844
Absent 65 6 5 1
Present 99 75 60 15
Histology 0.004 0.771
Differentiated 53 12 10 2
Undifferentiated 111 69 55 14
Lauren’s classification 0.006 0.021
Intestinal 45 8 6 2
Diffuse 81 53 47 6
Mixed 38 20 12 8
Proximal resection margin (cm) 0.032 0.910
≤2 37 31 25 6
2 - 4 51 22 17 5
≥4 76 28 23 5
Tumor size (cm) <0.001 0.771
≤2 19 0 0 0
2 - 5 65 12 10 2
>5 80 69 55 14
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Table 2 Correlations with clinicopathological factors, recurrence, and locoregional recurrence in the patients who
underwent curative total gastrectomy (Continued)
Tumor location <0.001 0.122
Lower third 7 7 4 3
Middle third 83 37 32 5
Upper third 64 19 13 6
Entire 10 18 16 2
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N-stage (P <0.023).
On univariate analysis, the pattern of recurrence had a
significant correlation with locoregional recurrence after
curative resection; these include gender (P <0.001), N-
stage (P = 0.013) and Lauren’s classification (P <0.021)
(Table 2). Multivariate analysis showed that the N-stage
was the only independent prognostic variable associated
with the locoregional recurrence (P = 0.039). The risk of
locoregional recurrence in patients with N3 was 2.677-
fold higher than that in patients with other N-stages
(hazard ratio: 3.484; 95% CI: 1.053 to 6.805).
On univariate analysis based on the Kaplan-Meier
method, the cumulative DFS was significantly shorter in
the patients with a shorter distance of the PRM as
compared with those with a longer distance of the PRM
(P = 0.019) (Figure 1). However, there was no significant
correlation between the cumulative locoregional recur-
rence and the PRM (P = 0.565). Ultimately, while the
PRM distance in total gastrectomy influenced the DFS,
it had no effect on the locoregional recurrence.
The mean distance of the PRM was 6.4 cm in the dis-
tal gastrectomy group. That is, there were 71 (13.4%),
187 (35.3%), and 271 (51.2%) patients where the distance
of the PRM was <3 cm, 3 to 6 cm, and >6 cm, respectively.Figure 1 Correlations between the distance of the PRM and
recurrence in patients who underwent curative total
gastrectomy. Kaplan-Meier curves for cumulative DFS with total
recurrence according to the distance of the PRM. DFS, disease-free
survival, PRM, proximal resection margin. The distance of the
proximal resection margin in the distal gastrectomy group.The distance of the PRM had a significant correlation with
advanced T-stage (P <0.001), advanced N-stage (P <0.001),
younger age (P = 0.044), vascular invasion (P = 0.013),
histological undifferentiation (P <0.001), greater tumor
size (P <0.001), and the middle third of the tumor location
(P <0.001) (Table 3).
There were 73 patients who had a tumor recurrence;
there were 26 cases of locoregional recurrence, 19 cases
of peritoneal carcinomatosis, 17 cases of hematogenous
metastasis, and 11 cases of multiple metastases. In
addition, the recurrence had a significant correlation
with T-stage (P <0.001), N-stage (P <0.001), vascular in-
vasion (P <0.001), lymphatic invasion (P <0.001), neural
invasion (P <0.001), tumor size (P <0.001), and tumor
location (P = 0.003) (Table 4). Multivariate analysis per-
formed by applying logistic regression showed that the
recurrence had a significant correlation with N-stage
(P <0.001), vascular invasion (P = 0.009), and the lower
third of tumor location (P = 0.035). On univariate analysis,
the pattern of recurrence had no significant correlation
with locoregional recurrence after curative resection
(Table 4). Multivariate analysis showed that the T-stage
was the only independent prognostic variable associated
with the locoregional recurrence (P = 0.021); the risk of
locoregional recurrence in T3-stage patients was 16.308-
fold higher than that in patients with other T-stage classi-
fications (hazard ratio: 3.484; 95% CI: 1.535 to 173.245).
On univariate analysis using the Kaplan-Meier method,
the cumulative DFS had no significant correlation with
the distance of the PRM (P = 0.089) (Figure 2). Also, there
was no significant correlation between the cumulative
locoregional recurrence and the PRM (P = 0.584).
Discussion
In the past, total gastrectomy was considered as a stand-
ard modality in patients with gastric cancer because it
could safely assure marginal distance [8,9]. However,
there were no significant differences in the survival rate
and complications between the subtotal and total gas-
trectomy in patients where the gastric cancer occurred
in the distal third of the stomach [8]. For successful
curative gastrectomy, obtaining appropriate resection
margin is crucial. The resection margin is determined
according to the degree of progression, pathologic find-
ings, location of cancer, and the chance of metastasis to
Table 3 Clinicopathological factors depending on the
distance of the proximal resection margin (PRM) in the
patients who underwent curative distal gastrectomy
Parameter PRM (cm) P value
≤3 3 - 6 ≥6
Gender 0.936
Male 47 138 189 374
Female 24 49 82 106
Age (years) 0.044
≤60 42 86 119 247
>60 29 101 152 282
T-stage <0.001
T1 29 97 181 307
T2 23 47 65 135
T3 18 42 24 84
T4 1 1 1 3
N-stage <0.001
N0 37 106 187 330
N1 14 42 60 116
N2 9 22 18 49
N3 11 17 6 34
Vascular invasion 0.013
Absent 59 158 248 465
Present 12 29 23 64
Lymphatic invasion 0.057
Absent 29 90 144 263
Present 42 97 127 266
Neural invasion 0.062
Absent 39 108 176 323
Present 32 79 95 206
Histology <0.001
Differentiated 20 67 146 233
Undifferentiated 51 120 125 296
Lauren’s classification 0.199
Intestinal 24 66 127 217
Diffuse 33 81 81 195
Mixed 14 40 63 117
Tumor size (cm) <0.001
≤3 25 68 151 244
3 - 5 14 46 60 120
≥5 32 73 60 165
Tumor location <0.001
Lower third 33 87 217 337
Middle third 38 100 54 192
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1 to 2 cm away from the pylorus, the first part of
duodenum. In contrast, the distance of the PRM for
gastrectomy remains controversial. It is mostly re-
commended, however, that the distance of the PRM
be set. This is because a positive margin is an inde-
pendent unfavorable factor for patients who undergo
gastrectomy.
According to Bozzetti et al. [4], the distance of the
PRM should be maintained at 3 cm in patients with gas-
tric cancer without serosal invasion, and >6 cm in those
with serosal invasion, or those for whom an accurate as-
sessment is not possible. According to this study, the
most important factor affecting cancer infiltration at re-
section margin is the primary tumor depth of the gastric
wall. It is statistically significant, regardless of cancer
location, size, gross findings, pathologic findings, and
lymph node positivity. According to the Japanese Gastric
Cancer Association (JGCA) guidelines, the distance of
the PRM should be 1 cm in patients with mucosal inva-
sion, 3 cm in those with well-differentiated muscle layer
and serosa, and >5 cm in those with histological undif-
ferentiation and serosal invasion [3]. Further, another re-
port stated that the length of cancer invasion along the
gastric wall was several millimeters at the margin of can-
cer lesion on gross findings in patients with intestinal
type gastric cancer, and several centimeters in those with
diffuse type gastric cancer [5]. Consistent with this, Gall
and Hermanek [10] reported that the length of cancer
invasion was >8 cm in patients with diffuse type gastric
cancer and >4 cm in patients with intestinal type gastric
cancer. Moreover, Ha and Kwon [5] reported that the
survival rate was significantly higher in patients with ad-
vanced gastric cancer located in the distal third who had
a >3-cm resection margin. In the current study, however,
there was no significant difference in survival rate be-
tween patients with advanced gastric cancer located in
the middle third and proximal third who had a >3-cm
resection margin, and those who had a <3-cm resection
margin. Moreover, our results also showed that the dis-
tance of the PRM had a significant correlation with the
advanced T-stage, advanced N-stage, vascular invasion,
lymphatic invasion, neural invasion, histological undif-
ferentiation, greater tumor size, and the upper third of
tumor location in patients who underwent total gastrec-
tomy. However, the recurrence had a significant correl-
ation with N-stage only. The distance of the PRM had a
significant correlation with advanced T-stage, advanced
N-stage, vascular invasion, lymphatic invasion, neural
invasion, histological undifferentiation, greater tumor
size, and the middle third of tumor location in patients
who underwent distal gastrectomy. However, the recur-
rence had a significant correlation with N-stage, vascu-
lar invasion, and the lower third of tumor location.
Table 4 Correlations with clinicopathological factors, recurrence, and locoregional recurrence in the patients who
underwent curative distal gastrectomy
Parameter Recurrence P value Locoregional recurrence P value
Negative Positive Negative Positive
Gender 0.348 0.172
Male 319 55 33 22
Female 137 18 14 4
Age (years) 0.302 0.100
≤60 217 30 16 14
>60 239 43 31 12
T-stage <0.001 0.599
T1 301 6 3 3
T2 111 24 14 10
T3 42 42 29 13
T4 2 1 1 0
N-stage <0.001 0.555
N0 326 4 2 2
N1 95 21 14 7
N2 26 23 17 6
N3 9 25 14 11
Vascular invasion <0.001 0.957
Absent 426 39 25 14
Present 30 34 22 12
Lymphatic invasion <0.001 0.682
Absent 256 7 5 2
Present 200 66 42 24
Neural invasion <0.001 0.975
Absent 306 17 11 6
Present 150 56 36 20
Histology 0.118 0.520
Differentiated 207 26 18 8
Undifferentiated 249 47 29 18
Lauren’s classification 0.356 0.275
Intestinal 192 25 18 7
Diffuse 167 28 19 9
Mixed 97 20 10 10
Proximal resection margin (cm) 0.054 0.275
≤3 55 16 10 6
3 - 6 161 26 14 12
≥6 240 31 23 8
Tumor size (cm) <0.001 0.862
≤3 240 4 3 1
3 - 5 102 18 12 6
≥5 114 51 32 19
Location 0.003 0.108
Lower third 279 58 40 18
Middle third 177 15 7 8
Ohe et al. World Journal of Surgical Oncology 2014, 12:296 Page 7 of 9
http://www.wjso.com/content/12/1/296
Figure 2 Correlations between the distance of the PRM and
recurrence in the patients who underwent curative distal
gastrectomy. Kaplan-Meier curves for cumulative DFS with total
recurrence according to the distance of the PRM. DFS, disease-free
survival, PRM, proximal resection margin.
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terns of recurrence in patients with gastric cancer
undergoing curative surgery; these include locoregional
recurrence, peritoneal dissemination, and distant metas-
tasis. The locoregional recurrence is the most common
in Western countries, but is rare in Asian countries
[11,12]. From this context, Sasako et al. [13] confirmed
that peritoneal dissemination was the main recurrence
type of gastric cancer after curative gastrectomy with an
extended lymphadenectomy according to the JCOG
(Japan Clinical Oncology Group) study 9501. In the
current study, we found that peritoneal dissemination
was the most common, followed by the multiple recur-
rences in the patients who underwent total gastrectomy.
In the patients who underwent distal gastrectomy, how-
ever, locoregional recurrence was the most common,
followed by peritoneal dissemination.
Deng et al. [14] analyzed 169 cases of recurrence in
patients with gastric cancer who were treated with cura-
tive resection, reporting that there was a significant cor-
relation between the locoregional recurrence and
Lauren’s classification. Moreover, Yoo et al. [15] ana-
lyzed 508 cases of recurrence in patients with gastric
cancer who were treated with potentially curative gas-
trectomy, reporting that 33% of total recurrences in-
volved the locoregional site. These authors also noted
that the locoregional recurrence had a significant correl-
ation with older age, large tumor size, diffuse type, and
proximal location. According to other studies, there are
clinicopathologic factors with a predictive value for the
locoregional recurrence and these include the proximal
location, older age, male sex, advanced stage (T3 to 4,
and Nodal metastasis), infiltrative growth, diffuse type,
and stromal resection [12,16,17]. In our clinical series of
patients, on univariate analysis, the male sex, N-stage,and Lauren’s classification had a significant correlation
with the locoregional recurrence after curative total gas-
trectomy. On multivariate analysis, however, the N-stage
was the only independent prognostic factor that was
found to be associated with the locoregional recurrence.
In patients who underwent curative distal gastrectomy,
however, no significant correlation with locoregional re-
currence was found on either univariate or multivariate
analysis.
It is generally recommended that the length of resection
margin be sufficient for lowering the chance of local recur-
rence, but this does not apply to all cases. Papachristou
and Fortner argued that at least a 6.5-cm resection margin
should be maintained to prevent local recurrence [6]. In
addition, Nakamura et al. [18] insisted that cancer inva-
sion at the resection margin is not frequent and meaning-
less in patients with early gastric cancer, although it is a
key prognostic factor. Consistent with this, Kim et al. [19]
reported that the distance of the PRM had no negative ef-
fects on the prognosis of patients with early gastric cancer.
According to these authors, there was a close relationship
between the distance of the PRM and the prognosis in pa-
tients with advanced gastric cancer, but they contradicted
the relationship between the distance of the PRM and
locoregional recurrence. Our results show that there was
no significant correlation between the locoregional recur-
rence and the distance of the PRM.Conclusions
In conclusion, our results indicate that a sufficient resec-
tion margin is not the absolute factor associated with
the rate of survival and recurrence, although it is a key
prognostic factor. The locoregional recurrence had no
significant correlation with the distance of the PRM after
curative gastrectomy. The distance of the PRM observed
in the operative field or the range of palpation is import-
ant, but it should be carefully evaluated as microscopic
tumor may be present depending on the characteristics
of the tumor. It would therefore be mandatory to intra-
operatively perform a frozen section biopsy of the PRM.
In addition, it is also necessary to avoid excessive resec-
tion in patients who are negative for an intraoperative
frozen section biopsy of the PRM, which is essential for
improving the quality of life and minimizing the occur-
rence of complications in patients undergoing curative
gastrectomy.Abbreviations
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